Supplemental Annuity Collective Trust (SACT) of New Jersey’s Gilead Sciences GILD Stock Holding History

Supplemental Annuity Collective Trust (SACT) of New Jersey’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Sell	7,963 -438	-5%	-$57.7K	0.26%	75
2026 Q1	$1.17M	Buy	8,401 +5,401	+180%	+$756K	0.33%	59
2025 Q4	$368K	Sell	3,000 -3,100	-51%	-$377K	0.1%	181
2025 Q3	$677K	Hold	6,100	–	–	0.18%	126
2025 Q2	$676K	Hold	6,100	–	–	0.19%	125
2025 Q1	$684K	Hold	6,100	–	–	0.21%	109
2024 Q4	$563K	Hold	6,100	–	–	0.17%	139
2024 Q3	$511K	Hold	6,100	–	–	0.15%	149
2024 Q2	$419K	Hold	6,100	–	–	0.13%	162
2024 Q1	$447K	Hold	6,100	–	–	0.14%	161
2023 Q4	$494K	Hold	6,100	–	–	0.17%	139
2023 Q3	$457K	Hold	6,100	–	–	0.17%	138
2023 Q2	$470K	Hold	6,100	–	–	0.17%	140
2023 Q1	$506K	Sell	6,100 -3,800	-38%	-$315K	0.2%	130
2022 Q4	$850K	Hold	9,900	–	–	0.35%	88
2022 Q3	$611K	Hold	9,900	–	–	0.27%	107
2022 Q2	$612K	Hold	9,900	–	–	0.24%	118
2022 Q1	$589K	Hold	9,900	–	–	0.19%	151
2021 Q4	$719K	Hold	9,900	–	–	0.22%	137
2021 Q3	$692K	Hold	9,900	–	–	0.23%	134
2021 Q2	$682K	Hold	9,900	–	–	0.22%	137
2021 Q1	$640K	Hold	9,900	–	–	0.22%	141
2020 Q4	$577K	Hold	9,900	–	–	0.21%	137
2020 Q3	$626K	Hold	9,900	–	–	0.26%	108
2020 Q2	$762K	Hold	9,900	–	–	0.35%	84
2020 Q1	$740K	Hold	9,900	–	–	0.41%	64
2019 Q4	$643K	Hold	9,900	–	–	0.27%	126
2019 Q3	$627K	Sell	9,900 -3,100	-24%	-$203K	0.29%	115
2019 Q2	$878K	Sell	13,000 -3,000	-19%	-$197K	0.39%	83
2019 Q1	$1.04M	Hold	16,000	–	–	0.46%	57
2018 Q4	$1M	Hold	16,000	–	–	0.51%	52
2018 Q3	$1.24M	Hold	16,000	–	–	0.51%	54
2018 Q2	$1.13M	Hold	16,000	–	–	0.49%	59
2018 Q1	$1.21M	Sell	16,000 -1,000	-6%	-$79.5K	0.53%	54
2017 Q4	$1.22M	Hold	17,000	–	–	0.51%	59
2017 Q3	$1.38M	Sell	17,000 -3,000	-15%	-$229K	0.6%	46
2017 Q2	$1.42M	Hold	20,000	–	–	0.63%	41
2017 Q1	$1.36M	Sell	20,000 -5,000	-20%	-$352K	0.61%	45
2016 Q4	$1.79M	Hold	25,000	–	–	0.85%	29
2016 Q3	$1.98M	Hold	25,000	–	–	0.98%	24
2016 Q2	$2.09M	Buy	25,000 +2,000	+9%	+$177K	1.04%	23
2016 Q1	$2.11M	Hold	23,000	–	–	1.07%	21
2015 Q4	$2.33M	Sell	23,000 -700	-3%	-$72.8K	1.18%	16
2015 Q3	$2.33M	Hold	23,700	–	–	1.23%	14
2015 Q2	$2.77M	Hold	23,700	–	–	1.33%	12
2015 Q1	$2.33M	Hold	23,700	–	–	1.09%	15
2014 Q4	$2.23M	Hold	23,700	–	–	1.05%	18
2014 Q3	$2.52M	Hold	23,700	–	–	1.23%	15
2014 Q2	$1.97M	Hold	23,700	–	–	0.95%	19
2014 Q1	$1.68M	Hold	23,700	–	–	0.83%	26
2013 Q4	$1.78M	Hold	23,700	–	–	0.88%	23
2013 Q3	$1.49M	Hold	23,700	–	–	0.81%	27
2013 Q2	$1.22M	Buy	+23,700	New	+$1.24M	0.69%	33

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Supplemental Annuity Collective Trust (SACT) of New Jersey's GILD Position: Q2 2026 in Review

Supplemental Annuity Collective Trust (SACT) of New Jersey reduced its Gilead Sciences (GILD) stake by 5.2% in Q2 2026, selling an estimated $57.7K and leaving 7,963 shares worth $1.01M. The position accounts for 0.26% of the portfolio, ranked #75.

Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.77M in Q2 2015. 1,755 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Supplemental Annuity Collective Trust (SACT) of New Jersey held 7,963 shares of Gilead Sciences worth $1.01M as of Q2 2026.
Supplemental Annuity Collective Trust (SACT) of New Jersey sold 438 Gilead Sciences shares in Q2 2026, an estimated $57.7K.
Gilead Sciences made up 0.26% of Supplemental Annuity Collective Trust (SACT) of New Jersey's portfolio in Q2 2026, its #75 holding.
Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
Supplemental Annuity Collective Trust (SACT) of New Jersey's Gilead Sciences position peaked at $2.77M in Q2 2015.
1,755 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Supplemental Annuity Collective Trust (SACT) of New Jersey's 13F filing for Q2 2026, filed 27 Jul 2026.